Prognostic and Predictive Biomarkers in Colorectal Cancer: Implications for the Clinical Surgeon
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Prognostic and Predictive Biomarkers in Colorectal Cancer: Implications for the Clinical Surgeon
Authors
Keywords
Vascular Endothelial Growth Factor, Epidermal Growth Factor Receptor, Familial Adenomatous Polyposis, Adenomatous Polyposis Coli, Lynch Syndrome
Journal
ANNALS OF SURGICAL ONCOLOGY
Volume 22, Issue 11, Pages 3433-3450
Publisher
Springer Nature
Online
2015-07-28
DOI
10.1245/s10434-015-4706-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Expression and Clinical Significance of MicroRNA-376a in Colorectal Cancer
- (2015) Zhan-Hao Mo et al. Asian Pacific Journal of Cancer Prevention
- MicroRNA-339-5p inhibits colorectal tumorigenesis through regulation of the MDM2/p53 signaling
- (2015) Cen Zhang et al. Oncotarget
- MicroRNA-130b Promotes Tumor Development and Is Associated with Poor Prognosis in Colorectal Cancer
- (2015) Tommaso Colangelo et al. NEOPLASIA
- The predictive value ofKRAS, NRAS, BRAF, PIK3CAand PTEN for anti-EGFR treatment in metastatic colorectal cancer: A systematic review and meta-analysis
- (2014) Christina Therkildsen et al. ACTA ONCOLOGICA
- Prognostic value of CpG island methylator phenotype among colorectal cancer patients: a systematic review and meta-analysis
- (2014) Y. Y. Juo et al. ANNALS OF ONCOLOGY
- Serum miR-19a Predicts Resistance to FOLFOX Chemotherapy in Advanced Colorectal Cancer Cases
- (2014) Qi Chen et al. Asian Pacific Journal of Cancer Prevention
- Expression of uPAR in tumor-associated stromal cells is associated with colorectal cancer patient prognosis: a TMA study
- (2014) Martin C Boonstra et al. BMC CANCER
- Prognostic impact of genomic instability in colorectal cancer
- (2014) T S Hveem et al. BRITISH JOURNAL OF CANCER
- Colorectal cancer statistics, 2014
- (2014) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- A novel colorectal cancer risk locus at 4q32.2 identified from an international genome-wide association study
- (2014) Stephanie L. Schmit et al. CARCINOGENESIS
- Association between miR-27a genetic variants and susceptibility to colorectal cancer
- (2014) Zaiqiu Wang et al. Diagnostic Pathology
- Clinical and biological significance of miR-378a-3p and miR-378a-5p in colorectal cancer
- (2014) Hui Li et al. EUROPEAN JOURNAL OF CANCER
- CpG Island Methylator Phenotype Is Associated With Response to Adjuvant Irinotecan-Based Therapy for Stage III Colon Cancer
- (2014) Stacey Shiovitz et al. GASTROENTEROLOGY
- Identification of MicroRNA-214 as a negative regulator of colorectal cancer liver metastasis by way of regulation of fibroblast growth factor receptor 1 expression
- (2014) Dong-liang Chen et al. HEPATOLOGY
- Tissue inhibitor of metalloproteinases (TIMP)-1 creates a premetastatic niche in the liver through SDF-1/CXCR4-dependent neutrophil recruitment in mice
- (2014) Bastian Seubert et al. HEPATOLOGY
- The prognostic role of microsatellite instability, codon-specificKRAS, andBRAFmutations in colon cancer
- (2014) Chun-Chi Lin et al. JOURNAL OF SURGICAL ONCOLOGY
- Validation of the 12-Gene Colon Cancer Recurrence Score as a Predictor of Recurrence Risk in Stage II and III Rectal Cancer Patients
- (2014) Marlies S. Reimers et al. JNCI-Journal of the National Cancer Institute
- Effect of BRAF V600E mutation on tumor response of anti-EGFR monoclonal antibodies for first-line metastatic colorectal cancer treatment: a meta-analysis of randomized studies
- (2014) Dandan Cui et al. MOLECULAR BIOLOGY REPORTS
- Large-scale genetic study in East Asians identifies six new loci associated with colorectal cancer risk
- (2014) Ben Zhang et al. NATURE GENETICS
- Initial Therapy with FOLFOXIRI and Bevacizumab for Metastatic Colorectal Cancer
- (2014) Fotios Loupakis et al. NEW ENGLAND JOURNAL OF MEDICINE
- MicroRNA-92a as a Potential Biomarker in Diagnosis of Colorectal Cancer: A Systematic Review and Meta-Analysis
- (2014) Xin Yang et al. PLoS One
- BRAFV600E Mutation and Its Association with Clinicopathological Features of Colorectal Cancer: A Systematic Review and Meta-Analysis
- (2014) Dong Chen et al. PLoS One
- Technical Factors Involved in the Measurement of Circulating MicroRNA Biomarkers for the Detection of Colorectal Neoplasia
- (2014) Atsushi Yamada et al. PLoS One
- Circulating MicroRNAs as a Novel Class of Diagnostic Biomarkers in Gastrointestinal Tumors Detection: A Meta-Analysis Based on 42 Articles
- (2014) Ran Wang et al. PLoS One
- MiR-139-5p inhibits migration and invasion of colorectal cancer by downregulating AMFR and NOTCH1
- (2014) Mingxu Song et al. Protein & Cell
- Survival in stage II/III colorectal cancer is independently predicted by chromosomal and microsatellite instability, but not by specific driver mutations
- (2013) Dmitri Mouradov et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Independent Validation of a Prognostic Genomic Signature (ColoPrint) for Patients With Stage II Colon Cancer
- (2013) Matthias Maak et al. ANNALS OF SURGERY
- EGFR, BRAF and KRAS Status in Patients Undergoing Pulmonary Metastasectomy from Primary Colorectal Carcinoma: A Prospective Follow-Up Study
- (2013) Thomas Schweiger et al. ANNALS OF SURGICAL ONCOLOGY
- Up-regulation of NEK2 by MicroRNA-128 Methylation is Associated with Poor Prognosis in Colorectal Cancer
- (2013) Yusuke Takahashi et al. ANNALS OF SURGICAL ONCOLOGY
- Integral analysis of p53 and its value as prognostic factor in sporadic colon cancer
- (2013) Arantza Fariña Sarasqueta et al. BMC CANCER
- The prognostic role of KRAS, BRAF, PIK3CA and PTEN in colorectal cancer
- (2013) V Eklöf et al. BRITISH JOURNAL OF CANCER
- KRAS-mutated plasma DNA as predictor of outcome from irinotecan monotherapy in metastatic colorectal cancer
- (2013) K G Spindler et al. BRITISH JOURNAL OF CANCER
- Prognostic Role of Tumor-Associated Proteases in Colorectal Cancer
- (2013) N. E. Kushlinskii et al. BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE
- Clinicopathological Significance of microRNA-31, -143 and -145 Expression in Colorectal Cancer
- (2013) Chao-Jie Wang et al. DISEASE MARKERS
- Everolimus in colorectal cancer
- (2013) Ivy Altomare et al. EXPERT OPINION ON PHARMACOTHERAPY
- Pleiotropic effects of genetic risk variants for other cancers on colorectal cancer risk: PAGE, GECCO and CCFR consortia
- (2013) Iona Cheng et al. GUT
- Phosphatidylinositol-3-kinase pathway aberrations in gastric and colorectal cancer: Meta-analysis, co-occurrence and ethnic variation
- (2013) Mei-Ling Chong et al. INTERNATIONAL JOURNAL OF CANCER
- Proangiogenic tumor proteins as potential predictive or prognostic biomarkers for bevacizumab therapy in metastatic colorectal cancer
- (2013) Maressa A. Bruhn et al. INTERNATIONAL JOURNAL OF CANCER
- Biologic Determinants of Tumor Recurrence in Stage II Colon Cancer: Validation Study of the 12-Gene Recurrence Score in Cancer and Leukemia Group B (CALGB) 9581
- (2013) Alan P. Venook et al. JOURNAL OF CLINICAL ONCOLOGY
- Validation of the 12-Gene Colon Cancer Recurrence Score in NSABP C-07 As a Predictor of Recurrence in Patients With Stage II and III Colon Cancer Treated With Fluorouracil and Leucovorin (FU/LV) and FU/LV Plus Oxaliplatin
- (2013) Greg Yothers et al. JOURNAL OF CLINICAL ONCOLOGY
- Prognostic Impact of Deficient DNA Mismatch Repair in Patients With Stage III Colon Cancer From a Randomized Trial of FOLFOX-Based Adjuvant Chemotherapy
- (2013) Frank A. Sinicrope et al. JOURNAL OF CLINICAL ONCOLOGY
- miR-181a is associated with poor clinical outcome in patients with colorectal cancer treated with EGFR inhibitor
- (2013) Martin Pichler et al. JOURNAL OF CLINICAL PATHOLOGY
- Decreased expression of microRNA-625 is associated with tumor metastasis and poor prognosis in patients with colorectal cancer
- (2013) Xiaolou Lou et al. JOURNAL OF SURGICAL ONCOLOGY
- Defective Mismatch Repair and Benefit from Bevacizumab for Colon Cancer: Findings from NSABP C-08
- (2013) Kay Pogue-Geile et al. JNCI-Journal of the National Cancer Institute
- Predictive and Prognostic Analysis of PIK3CA Mutation in Stage III Colon Cancer Intergroup Trial
- (2013) Shuji Ogino et al. JNCI-Journal of the National Cancer Institute
- KRAS as prognostic biomarker in metastatic colorectal cancer patients treated with bevacizumab: a pooled analysis of 12 published trials
- (2013) Fausto Petrelli et al. MEDICAL ONCOLOGY
- Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA
- (2013) Muhammed Murtaza et al. NATURE
- Panitumumab–FOLFOX4 Treatment and RAS Mutations in Colorectal Cancer
- (2013) Jean-Yves Douillard et al. NEW ENGLAND JOURNAL OF MEDICINE
- Discovery of colorectal cancer PIK3CA mutation as potential predictive biomarker: power and promise of molecular pathological epidemiology
- (2013) S Ogino et al. ONCOGENE
- Meta-Analysis of the Association between a Polymorphism in MicroRNA-196a2 and Susceptibility to Colorectal Cancer
- (2013) Ke-Qing Shi et al. ONKOLOGIE
- EGFR Gene Copy Number as a Prognostic Marker in Colorectal Cancer Patients Treated with Cetuximab or Panitumumab: A Systematic Review and Meta Analysis
- (2013) Zheng Jiang et al. PLoS One
- MicroRNA-18a Attenuates DNA Damage Repair through Suppressing the Expression of Ataxia Telangiectasia Mutated in Colorectal Cancer
- (2013) Chung-Wah Wu et al. PLoS One
- The Genetic Variant on Chromosome 10p14 Is Associated with Risk of Colorectal Cancer: Results from a Case-Control Study and a Meta-Analysis
- (2013) Qin Qin et al. PLoS One
- The Prognostic Role of BRAF Mutation in Metastatic Colorectal Cancer Receiving Anti-EGFR Monoclonal Antibodies: A Meta-Analysis
- (2013) Zi-Xu Yuan et al. PLoS One
- MiR-124 Suppresses Growth of Human Colorectal Cancer by Inhibiting STAT3
- (2013) Jufeng Zhang et al. PLoS One
- Prognostic Role of microRNA-21 in Colorectal Cancer: a Meta-Analysis
- (2013) Xiaochun Xia et al. PLoS One
- Can K-ras Gene Mutation Be Utilized as Prognostic Biomarker for Colorectal Cancer Patients Receiving Chemotherapy? A Meta-Analysis and Systematic Review
- (2013) Yuan-Yi Rui et al. PLoS One
- The Association between Two MicroRNA Variants (miR-499, miR-149) and Gastrointestinal Cancer Risk: A Meta-Analysis
- (2013) Li Li et al. PLoS One
- Thymidylate synthase expression and p21WAF1/p53 phenotype of colon cancers identify patients who may benefit from 5-fluorouracil based therapy
- (2013) Violetta Sulzyc-Bielicka et al. CELLULAR ONCOLOGY
- MicroRNA-10b is a Prognostic Indicator in Colorectal Cancer and Confers Resistance to the Chemotherapeutic Agent 5-Fluorouracil in Colorectal Cancer Cells
- (2012) Naohiro Nishida et al. ANNALS OF SURGICAL ONCOLOGY
- Combined CD133/CD44 Expression as a Prognostic Indicator of Disease-Free Survival in Patients With Colorectal Cancer
- (2012) Gennaro Galizia ARCHIVES OF SURGERY
- Down-regulation of KRAS-interacting miRNA-143 predicts poor prognosis but not response to EGFR-targeted agents in colorectal cancer
- (2012) M Pichler et al. BRITISH JOURNAL OF CANCER
- Relationship of increased aurora kinase A gene copy number, prognosis and response to chemotherapy in patients with metastatic colorectal cancer
- (2012) E Dotan et al. BRITISH JOURNAL OF CANCER
- The TERT variant rs2736100 is associated with colorectal cancer risk
- (2012) B Kinnersley et al. BRITISH JOURNAL OF CANCER
- MMP-2 and MMP-9 in normal mucosa are independently associated with outcome of colorectal cancer patients
- (2012) A M J Langers et al. BRITISH JOURNAL OF CANCER
- Loss of PTEN expression as a predictor of resistance to anti-EGFR monoclonal therapy in metastatic colorectal cancer: evidence from retrospective studies
- (2012) Zhen-Hua Wang et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- MiR-429 is an independent prognostic factor in colorectal cancer and exerts its anti-apoptotic function by targeting SOX2
- (2012) Juan Li et al. CANCER LETTERS
- miR-103/107 Promote Metastasis of Colorectal Cancer by Targeting the Metastasis Suppressors DAPK and KLF4
- (2012) H.-Y. Chen et al. CANCER RESEARCH
- Downregulation of miR-144 is associated with colorectal cancer progression via activation of mTOR signaling pathway
- (2012) Takeshi Iwaya et al. CARCINOGENESIS
- Lack of Bax expression is associated with irinotecan-based treatment activity in advanced colorectal cancer patients
- (2012) F. Pietrantonio et al. Clinical & Translational Oncology
- Prognostic Role of PIK3CA Mutation in Colorectal Cancer: Cohort Study and Literature Review
- (2012) X. Liao et al. CLINICAL CANCER RESEARCH
- Overexpression of miR-92a correlates with tumor metastasis and poor prognosis in patients with colorectal cancer
- (2012) Tong Zhou et al. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE
- Association ofKRASG13D Tumor Mutations With Outcome in Patients With Metastatic Colorectal Cancer Treated With First-Line Chemotherapy With or Without Cetuximab
- (2012) Sabine Tejpar et al. JOURNAL OF CLINICAL ONCOLOGY
- Systematic Meta-Analyses and Field Synopsis of Genetic Association Studies in Colorectal Cancer
- (2012) E. Theodoratou et al. JNCI-Journal of the National Cancer Institute
- miRNA Profiling in Colorectal Cancer Highlights miR-1 Involvement in MET-Dependent Proliferation
- (2012) J. F. Reid et al. MOLECULAR CANCER RESEARCH
- Genome-wide association analyses in east Asians identify new susceptibility loci for colorectal cancer
- (2012) Wei-Hua Jia et al. NATURE GENETICS
- Aspirin Use, TumorPIK3CAMutation, and Colorectal-Cancer Survival
- (2012) Xiaoyun Liao et al. NEW ENGLAND JOURNAL OF MEDICINE
- Computational Analysis of mRNA Expression Profiles Identifies MicroRNA-29a/c as Predictor of Colorectal Cancer Early Recurrence
- (2012) Tai-Yue Kuo et al. PLoS One
- Plasma miR-601 and miR-760 Are Novel Biomarkers for the Early Detection of Colorectal Cancer
- (2012) Qifeng Wang et al. PLoS One
- The Prognostic Value of BRAF Mutation in Colorectal Cancer and Melanoma: A Systematic Review and Meta-Analysis
- (2012) Gholamreza Safaee Ardekani et al. PLoS One
- The Clinical Significance of MiR-148a as a Predictive Biomarker in Patients with Advanced Colorectal Cancer
- (2012) Masanobu Takahashi et al. PLoS One
- Detection of Chromosomal Alterations in the Circulation of Cancer Patients with Whole-Genome Sequencing
- (2012) R. J. Leary et al. Science Translational Medicine
- Matrix metalloproteinase 9 expression and prognosis in colorectal cancer: a meta-analysis
- (2012) Chun-Yu Li et al. TUMOR BIOLOGY
- Elevated oncofoetal miR-17-5p expression regulates colorectal cancer progression by repressing its target gene P130
- (2012) Yanlei Ma et al. Nature Communications
- Mutant N-RAS Protects Colorectal Cancer Cells from Stress-Induced Apoptosis and Contributes to Cancer Development and Progression
- (2012) Yufang Wang et al. Cancer Discovery
- The role of Cathepsin S as a marker of prognosis and predictor of chemotherapy benefit in adjuvant CRC: a pilot study
- (2011) J A Gormley et al. BRITISH JOURNAL OF CANCER
- Prognostic Significance of miR-215 in Colon Cancer
- (2011) Mihriban Karaayvaz et al. Clinical Colorectal Cancer
- miR-150 as a potential biomarker associated with prognosis and therapeutic outcome in colorectal cancer
- (2011) Yanlei Ma et al. GUT
- Candidate microRNA biomarkers in human colorectal cancer: Systematic review profiling studies and experimental validation
- (2011) Yanlei Ma et al. INTERNATIONAL JOURNAL OF CANCER
- Impact ofKRASandBRAFGene Mutation Status on Outcomes From the Phase III AGITG MAX Trial of Capecitabine Alone or in Combination With Bevacizumab and Mitomycin in Advanced Colorectal Cancer
- (2011) Timothy J. Price et al. JOURNAL OF CLINICAL ONCOLOGY
- Validation Study of a Quantitative Multigene Reverse Transcriptase–Polymerase Chain Reaction Assay for Assessment of Recurrence Risk in Patients With Stage II Colon Cancer
- (2011) Richard G. Gray et al. JOURNAL OF CLINICAL ONCOLOGY
- Value of Mismatch Repair, KRAS, and BRAF Mutations in Predicting Recurrence and Benefits From Chemotherapy in Colorectal Cancer
- (2011) Gordon Hutchins et al. JOURNAL OF CLINICAL ONCOLOGY
- Downregulation of miR-195 correlates with lymph node metastasis and poor prognosis in colorectal cancer
- (2011) Xueqing Wang et al. MEDICAL ONCOLOGY
- Clinical significance of the plasminogen activator system in relation to grade of tumor and treatment response in colorectal carcinoma patients
- (2011) J. HALAMKOVA et al. NEOPLASMA
- Circulating Plasma MiR-141 Is a Novel Biomarker for Metastatic Colon Cancer and Predicts Poor Prognosis
- (2011) Hanyin Cheng et al. PLoS One
- Implications of microRNAs in Colorectal Cancer Development, Diagnosis, Prognosis, and Therapeutics
- (2011) Haiyan Zhai et al. Frontiers in Genetics
- The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM
- (2010) Stephen B. Edge et al. ANNALS OF SURGICAL ONCOLOGY
- Tumor infiltrating lymphocytes: an intriguing player in the survival of colorectal cancer patients
- (2010) Vanessa Deschoolmeester et al. BMC IMMUNOLOGY
- Characterization of 9p24 Risk Locus and Colorectal Adenoma and Cancer: Gene-Environment Interaction and Meta-Analysis
- (2010) J. D. Kocarnik et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- NRAS Mutations Are Rare in Colorectal Cancer
- (2010) Natsumi Irahara et al. DIAGNOSTIC MOLECULAR PATHOLOGY
- Critical analysis of mucin and signet ring cell as prognostic factors in an Asian population of 2,764 sporadic colorectal cancers
- (2010) Min-Hoe Chew et al. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE
- BM-ca is a newly defined type I/II anti-CD20 monoclonal antibody with unique biological properties
- (2010) Nishida INTERNATIONAL JOURNAL OF ONCOLOGY
- Relationship Between Tumor Gene Expression and Recurrence in Four Independent Studies of Patients With Stage II/III Colon Cancer Treated With Surgery Alone or Surgery Plus Adjuvant Fluorouracil Plus Leucovorin
- (2010) Michael J. O'Connell et al. JOURNAL OF CLINICAL ONCOLOGY
- Gene Expression Signature to Improve Prognosis Prediction of Stage II and III Colorectal Cancer
- (2010) Ramon Salazar et al. JOURNAL OF CLINICAL ONCOLOGY
- Circulating miR-221 directly amplified from plasma is a potential diagnostic and prognostic marker of colorectal cancer and is correlated with p53 expression
- (2010) Xing-xiang Pu et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis
- (2010) Wendy De Roock et al. LANCET ONCOLOGY
- Down-regulation of miR-126 expression in colorectal cancer and its clinical significance
- (2010) Xiang-Min Li et al. MEDICAL ONCOLOGY
- Clinicopathological significance of prolactin receptor expression in colorectal carcinoma and corresponding metastases
- (2010) Lars Harbaum et al. MODERN PATHOLOGY
- BRAF V600E mutation and resistance to anti-EGFR monoclonal antibodies in patients with metastatic colorectal cancer: a meta-analysis
- (2010) Chen Mao et al. MOLECULAR BIOLOGY REPORTS
- Meta-analysis of three genome-wide association studies identifies susceptibility loci for colorectal cancer at 1q41, 3q26.2, 12q13.13 and 20q13.33
- (2010) Richard S Houlston et al. NATURE GENETICS
- Tumor budding predicts response to anti-EGFR therapies in metastatic colorectal cancer patients
- (2010) Inti Zlobec WORLD JOURNAL OF GASTROENTEROLOGY
- PIK3CA Mutations in Colorectal Cancer Are Associated with Clinical Resistance to EGFR-Targeted Monoclonal Antibodies
- (2009) A. Sartore-Bianchi et al. CANCER RESEARCH
- PIK3CA Mutations Predict Local Recurrences in Rectal Cancer Patients
- (2009) Y. He et al. CLINICAL CANCER RESEARCH
- Local recurrence in rectal cancer can be predicted by histopathological factors
- (2009) R.C. Dresen et al. EJSO
- Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening
- (2009) E K O Ng et al. GUT
- American Society of Clinical Oncology Provisional Clinical Opinion: Testing forKRASGene Mutations in Patients With Metastatic Colorectal Carcinoma to Predict Response to Anti–Epidermal Growth Factor Receptor Monoclonal Antibody Therapy
- (2009) Carmen J. Allegra et al. JOURNAL OF CLINICAL ONCOLOGY
- Amphiregulin and Epiregulin mRNA Expression in Primary Tumors Predicts Outcome in Metastatic Colorectal Cancer Treated With Cetuximab
- (2009) Bart Jacobs et al. JOURNAL OF CLINICAL ONCOLOGY
- PIK3CAMutation Is Associated With Poor Prognosis Among Patients With Curatively Resected Colon Cancer
- (2009) Shuji Ogino et al. JOURNAL OF CLINICAL ONCOLOGY
- Mechanism of chemoresistance mediated by miR-140 in human osteosarcoma and colon cancer cells
- (2009) B Song et al. ONCOGENE
- Dicer-regulated microRNAs 222 and 339 promote resistance of cancer cells to cytotoxic T-lymphocytes by down-regulation of ICAM-1
- (2009) R. Ueda et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Association of survival and disease progression with chromosomal instability: A genomic exploration of colorectal cancer
- (2009) M. Sheffer et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Prognostic significance of thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase protein expression in colorectal cancer patients treated with or without 5-fluorouracil-based chemotherapy
- (2008) R. Soong et al. ANNALS OF ONCOLOGY
- miRiad Roles for the miR-17-92 Cluster in Development and Disease
- (2008) Joshua T. Mendell CELL
- Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases
- (2008) Xi Chen et al. CELL RESEARCH
- Deregulated expression of miR-106a predicts survival in human colon cancer patients
- (2008) Raquel Díaz et al. GENES CHROMOSOMES & CANCER
- Association between chromosomal instability and prognosis in colorectal cancer: a meta-analysis
- (2008) A Walther et al. GUT
- Increased TGF-Beta1 protein expression in patients with advanced colorectal cancer
- (2008) Marcus Langenskiöld et al. JOURNAL OF SURGICAL ONCOLOGY
- Folylpolyglutamate synthase and γ-glutamyl hydrolase regulate leucovorin-enhanced 5-fluorouracil anticancer activity
- (2007) Etsuko Sakamoto et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now